BridgeMD
New treatment option for Cerebral Palsy
Official title Investıgatıon Of The Effectıveness Of The Mollıı Suıt In Chıldren Wıth Ambulatory Cerebral Palsy
ClinicalTrials.gov ID: NCT06109129
What this study is testing
- What it's testing
- Cerebral Palsy (CP) is the most common developmental disorder in childhood. Individuals' independence in daily living activities and participation in education, games, social and community activities are restricted.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 18
You may be able to join if
- Being a voluntary participant in the study,
- Having a diagnosis of spastic CP,
- Being between 1-3 on the Gross Motor Classification System (GMFCS),
- Being between the ages of 4 and 18,
- Being able to express pain and discomfort
You likely can't join if
- Being between 4-5 on Gross Motor Classification System (GMFCS)
- Having Botolunim Toxin A application before 3 months
- Having a surgical intervention before 6 months
- Having a shunt or an invasive medical pump (baclofen, insulin, etc.)
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.